Skip to main content
Equibles

Sanjay Shukla

CEO

aTYR PHARMA INC (ATYR)

Board Member

aTYR PHARMA INC (ATYR)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Sanjay Shukla

Sanjay Shukla is recorded as CEO and Board Member at aTYR PHARMA INC (ATYR). The proxy statement of aTYR PHARMA INC reports total compensation of $3,456,253 for Sanjay Shukla in fiscal 2025, including a base salary of $638,977. Disclosed compensation is on record for 8 fiscal years. Sanjay Shukla has spoken on 14 earnings calls and 5 other investor events across 1 company, most recently for aTYR PHARMA INC on June 4, 2026.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at aTYR PHARMA INC

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 aTYR PHARMA INC (ATYR) $638,977 $3,456,253
2024 aTYR PHARMA INC (ATYR) $580,887 $1,480,522
2023 aTYR PHARMA INC (ATYR) $561,243 $1,300,525
2022 aTYR PHARMA INC (ATYR) $561,243 $2,411,435
2021 aTYR PHARMA INC (ATYR) $510,221 $1,892,708
2020 aTYR PHARMA INC (ATYR) $470,250 $1,083,857
2019 aTYR PHARMA INC (ATYR) $450,000 $663,961
2018 aTYR PHARMA INC (ATYR) $450,000 $1,380,465

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Show 7 earlier activities